Kangmei Pharma | 600518 - Operating Profit

Stock Price
1.91
Daily Change
-0.02 -1.04%
Monthly
-1.04%
Yearly
-12.79%
Q1 Forecast
1.85

Kangmei Pharma reported CNY-26.7M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 432K Sep/2025
Avita Medical AUD -11.15M 1.19M Jun/2025
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Genomma Lab Internacional MXN 800.61M 167.16M Dec/2025
Hypermarcas BRL 673.59M 27.56M Sep/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Jiangsu Hengrui CNY 1.41B 1.4B Sep/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Sh Fosun Pharma CNY 758.38M 67.22M Sep/2025
Tectonic Therapeutic USD -21.89M 440K Sep/2025
Viatris USD -157.5M 392M Dec/2025
Wuxi Apptec CNY 4.97B 1.19B Sep/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025
Zz Pientze Pharmaceu CNY 501.33M 52.54M Sep/2025